Literature DB >> 28229969

MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.

Hongbin Bao1, Xinguo Li, Hengli Li, Hongli Xing, Binghui Xu, Xianfeng Zhang, Zhaoming Liu.   

Abstract

MicroRNA 144 (miR-144), a small non-coding RNA, is frequently dysregulated in human several tumour progression, but its role and the underlying mechanisms in hepatocellular carcinoma (HCC) is poorly investigated. In the present study, the expression of miR-144 was firstly analysed in datasets derived from GSE21362 and TCGA, and then detected in HCC tissues and cell lines by quantitative RT-PCR (qRT-PCR) analysis. MiR-144 was shown to be significantly down-regulated in HCC tissues and cell lines. Subsequently, overexpression of miR-144 was transfected into HCC cell lines so as to investigate its biological function, including MTT, colony formation, and transwell assays. Gain of function assay revealed miR-144 remarkably inhibited cell proliferation, migration and invasion. In addition, bioinformatical analysis and luciferase reporter assay identified ZFX as a novel target of miR-144 in HCC cells, as confirmed by qRT-PCR and Western blot. Furthermore, ZFX was found to be significantly up-regulated using Oncomine database analysis. Loss of function assay further indicated knockdown of ZFX had similar effects of miR-144-mediated HCC cell proliferation and invasion. Therefore, miR-144 has been demonstrated to act as a tumour suppressor in HCC cell growth and motility by directly targeting ZFX, which implicates its potential applications in the development of HCC treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28229969     DOI: 10.1007/s12038-016-9662-5

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  24 in total

1.  MicroRNAs control hepatocyte proliferation during liver regeneration.

Authors:  Guisheng Song; Amar Deep Sharma; Garrett R Roll; Raymond Ng; Andrew Y Lee; Robert H Blelloch; Niels M Frandsen; Holger Willenbring
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

2.  MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.

Authors:  Xin Yang; Xiao-Fei Zhang; Xu Lu; Hu-Liang Jia; Lei Liang; Qiong-Zhu Dong; Qing-Hai Ye; Lun-Xiu Qin
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

3.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

Authors:  Girish C Shukla; Jagjit Singh; Sailen Barik
Journal:  Mol Cell Pharmacol       Date:  2011

4.  Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.

Authors:  Keng Po Lai; Jiawei Chen; Mian He; Arthur K K Ching; Coleen Lau; Paul B S Lai; Ka-Fai To; Nathalie Wong
Journal:  Int J Cancer       Date:  2014-03-11       Impact factor: 7.396

5.  Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.

Authors:  Bin-Hui Xie; Xiao He; Rui-Xi Hua; Bing Zhang; Guo-Sheng Tan; Shi-Qiu Xiong; Liang-Shuai Liu; Wei Chen; Jian-Yong Yang; Xiao-Nong Wang; He-Ping Li
Journal:  Cancer Biomark       Date:  2016       Impact factor: 4.388

Review 6.  MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?

Authors:  P Mathijs Voorhoeve
Journal:  Biochim Biophys Acta       Date:  2009-09-10

7.  MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.

Authors:  Cheng Xiang; Shi-Peng Cui; You Ke
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

8.  Stable isotope dimethyl labeling combined with LTQ mass spectrometric detection, a quantitative proteomics technology used in liver cancer research.

Authors:  Bo Tang; Yang Li; Liang Zhao; Shengguang Yuan; Zhenran Wang; Bo Li; Qian Chen
Journal:  Biomed Rep       Date:  2013-05-09

9.  miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells.

Authors:  T Higashi; H Hayashi; T Ishimoto; H Takeyama; T Kaida; K Arima; K Taki; K Sakamoto; H Kuroki; H Okabe; H Nitta; D Hashimoto; A Chikamoto; T Beppu; H Baba
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

10.  miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.

Authors:  Run-Fa Bao; Yi-Jun Shu; Yun-Ping Hu; Xu-An Wang; Fei Zhang; Hai-Bin Liang; Yuan-Yuan Ye; Huai-Feng Li; Shan-Shan Xiang; Hao Weng; Yang Cao; Xiang-Song Wu; Mao-Lan Li; Wen-Guang Wu; Yi-Jian Zhang; Lin Jiang; Qian Dong; Ying-Bin Liu
Journal:  Oncotarget       Date:  2016-04-19
View more
  16 in total

1.  Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.

Authors:  Jing Liu; Liguo Feng; Haitao Zhang; Jin Zhang; Yanyan Zhang; Shujing Li; Long Qin; Ziyao Yang; Jianxia Xiong
Journal:  Cancer Biol Ther       Date:  2018-03-26       Impact factor: 4.742

2.  MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.

Authors:  Yuanqin Yin; Jingjing Cai; Fandong Meng; Chengguang Sui; Youhong Jiang
Journal:  Cancer Biol Ther       Date:  2018-03-26       Impact factor: 4.742

3.  Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining.

Authors:  Piyou Ji; Haitao Wang; Yu Cheng; Shaohua Liang
Journal:  J Gastrointest Oncol       Date:  2021-12

4.  HOXA-AS2 promotes type I endometrial carcinoma via miRNA-302c-3p-mediated regulation of ZFX.

Authors:  Ning Song; Ying Zhang; Fanfei Kong; Hui Yang; Xiaoxin Ma
Journal:  Cancer Cell Int       Date:  2020-07-31       Impact factor: 5.722

5.  [miR-144-3p Inhibits the Invasion and Metastasis of Lung Adenocarcinoma Cells 
by Targeting IRS1].

Authors:  Jun Bai; Yaqiong Hu; Xinlu Chen; Lin Chen; Liping Zhang; Chonggao Yin; Hongli Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-05-20

6.  Effect and Mechanism of miR-26a-5p on Proliferation and Apoptosis of Hepatocellular Carcinoma Cells.

Authors:  Wen-Jing Zhu; Ying Yan; Jiu-Wei Zhang; Yan-Dong Tang; Bo Han
Journal:  Cancer Manag Res       Date:  2020-04-30       Impact factor: 3.989

Review 7.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

8.  Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma.

Authors:  Ya-Guang Peng; Li Zhang
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

9.  Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma.

Authors:  Chunwen Pu; Hui Huang; Zhidong Wang; Wei Zou; Yuecai Lv; Zhiyuan Zhou; Qiqi Zhang; Liang Qiao; Fei Wu; Shujuan Shao
Journal:  Front Physiol       Date:  2018-07-17       Impact factor: 4.566

10.  Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2.

Authors:  Chao Liu; Zuozhang Yang; Zhiyong Deng; Youjun Zhou; Quan Gong; Ruilian Zhao; Ting Chen
Journal:  Cancer Med       Date:  2018-10-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.